P-caine Eye Drops
Proparacaine Hydrochloride sterile eye drops is indicated for procedures in which a topical ophthalmic anesthetic is indicated: corneal anesthesia of short duration, e.g., tonometry, gonioscopy, removal of corneal foreign bodies, and for short corneal and conjunctival procedures.
Dosage & Administration
Deep anesthesia as in cataract extraction: Instill 1 drop to the eye every 5 to 10 minutes for 5 to 7 doses.
Removal of sutures: Instill 1 or 2 drops to the eye 2 or 3 minutes before removal of stitches.
Removal of foreign bodies: Instill 1 or 2 drops to the eye prior to operating.
Tonometry: Instill 1 or 2 drops to the eye immediately before measurement.
Prolonged use of a topical ocular anesthetic is not recommended. It may produce permanent corneal opacification with accompanying visual loss.
Pregnancy: Category C
Animal reproduction studies have not been conducted with Proparacaine Hydrochloride sterile eye drops 0.5%. It is also not known whether Proparacaine Hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Proparacaine Hydrochloride should be administered to a pregnant woman only if clearly needed.
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Proparacaine Hydrochloride is administered to a nursing mother.
Safety and effectiveness of Proparacaine Hydrochloride sterile eye drops in pediatric patients have been established. Use of Proparacaine Hydrochloride is supported by evidence from adequate and well-controlled studies in adults and children over the age of twelve, and safety information in neonates and other pediatric patients.
No overall clinical differences in safety or effectiveness have been observed between the elderly and other adult patients.